Christopher Peetz
President and CEO
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Executive Officer | $755,000 | $10,441,224 |
| 2024 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Executive Officer | $730,000 | $6,598,551 |
| 2023 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Executive Officer | $660,000 | $6,451,720 |
| 2022 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Executive Officer | $624,000 | $4,402,664 |
| 2021 | Mirum Pharmaceuticals, Inc. (MIRM) | President and Chief Executive Officer | $600,000 | $4,130,831 |
| 2020 | Mirum Pharmaceuticals, Inc. (MIRM) | President and Chief Executive Officer | $511,818 | $3,003,978 |
| 2019 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Executive Officer and President | $457,614 | $6,235,185 |
| 2018 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Executive Officer and President | $32,083 | $32,083 |
Earnings-call appearances
-
H.C. Wainwright 4th Annual BioConnect Investor Conference2026-05-19
Mirum Pharmaceuticals, Inc. (MIRM)
-
Mirum Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-05-08
Mirum Pharmaceuticals, Inc. (MIRM)
-
Mirum Pharmaceuticals, Inc. Q4 FY2023 Earnings Call2024-02-28
Mirum Pharmaceuticals, Inc. (MIRM)
-
Mirum Pharmaceuticals, Inc. Q3 FY2023 Earnings Call2023-11-02
Mirum Pharmaceuticals, Inc. (MIRM)